Targeting MET in EGFR resistance in non-small-cell lung cancer—ready for daily practice?
Sabine Schmid, Martin Früh, Solange Peters
Topics & Concepts
AfatinibOsimertinibMedicineGefitinibErlotinibLung cancerT790MCancer researchTyrosine kinaseOncologyResistance mutationInternal medicineCancerEpidermal growth factor receptorBiologyReceptorGeneticsReverse transcriptaseRNAGeneLung Cancer Treatments and MutationsCholangiocarcinoma and Gallbladder Cancer StudiesCancer therapeutics and mechanisms